• {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
    • {%itemName%} {%arrowSpan%}
    • {%selfProduct%}
      • {%languages%}
    • This website is for UK Healthcare Professionals only


      September: Episode 3     Watch time: 15 min

      Psoriasis in practice: BAD guideline updates

      The third episode focuses on how dermatologists have been working with the recent BAD guideline updates in the clinic.2,3

      Podcast Series Host

      Dr Laura Savage

      University of Leeds and Leeds

      Teaching Hospitals NHS Trust

      Podcast Guest Speakers

      Rebecca Batchelor

      Royal Devon and Exeter NHS Foundation Trust


      Dr Hywel Cooper

      Portsmouth Hospitals NHS Trust




      JULY: Episode 1

      Clinical trial spotlight - risankizumab and secukinumab head-to-head in plaque psoriasis

      AUGUST: Episode 2

      Psoriasis in the time of COVID-19: an era of virtual clinics?             

      SEPTEMBER: Episode 3

      Psoriasis in practice: BAD guideline updates                               

      OCTOBER: Episode 4

      BAD 2020: virtual congress highlights

      NOVEMBER: Episode 5

      Are all IL-23s the same?                    

      DECEMBER: Episode 6

      EADV 2020: congress highlights       


      1. SKYRIZI (risankizumab) Summary of Product Characteristics.
      2. Smith CH, et al. BJD 2020, Published: March 18, 2020. DOI:10.1111/bjd.19039.
      3. Clinicaltrials.gov NCT03478787. https://clinicaltrials.gov/ct2/show/NCT03478787 (Accessed August 2020).

      UK-RISN-210515 Date of Preparation: November 2021